eFFECTOR Therapeutics, Inc. (EFTR)
NASDAQ: EFTR · IEX Real-Time Price · USD
1.890
+0.080 (4.42%)
At close: Apr 26, 2024, 4:00 PM
1.930
+0.040 (2.12%)
After-hours: Apr 26, 2024, 7:35 PM EDT
eFFECTOR Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
14
Market Cap
6.97M USD
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 0 | - | - |
| Dec 31, 2022 | 3.55M | 2.12M | 148.46% |
| Dec 31, 2021 | 1.43M | -40.57M | -96.60% |
| Dec 31, 2020 | 42.00M | - | - |
| Dec 31, 2019 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Clever Leaves Holdings | 17.42M |
| Kineta | 5.44M |
| Plus Therapeutics | 4.91M |
| Assure Holdings | 3.57M |
| Creative Medical Technology Holdings | 9.00K |
EFTR News
- 17 days ago - eFFECTOR Therapeutics to Participate in Upcoming Investor Conference - GlobeNewsWire
- 22 days ago - eFFECTOR Therapeutics Announces Topline Results of Phase 2 KICKSTART Trial of Tomivosertib Combined with Pembrolizumab in Non-Small Cell Lung Cancer - GlobeNewsWire
- 4 weeks ago - eFFECTOR Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - eFFECTOR Therapeutics to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference - GlobeNewsWire
- 3 months ago - eFFECTOR Therapeutics Announces Closing of $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - GlobeNewsWire
- 3 months ago - eFFECTOR Therapeutics Announces $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - GlobeNewsWire
- 3 months ago - eFFECTOR Therapeutics to Host Virtual Investor R&D Day on January 24, 2024 - GlobeNewsWire
- 3 months ago - eFFECTOR Therapeutics Announces Reverse Stock Split - GlobeNewsWire